T. Rowe Price Investment Management
HCA icon

T. Rowe Price Investment Management’s HCA Healthcare HCA Stock Holding History

T. Rowe Price Investment Management’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$399M Buy
1,023,107
+1,021,279
+55,869% +$432M 0.26% 103
2026
Q1 		$866K Sell
1,828
-206
-10% -$104K ﹤0.01% 624
2025
Q4 		$950K Buy
2,034
+289
+17% +$134K ﹤0.01% 643
2025
Q3 		$744K Sell
1,745
-108
-6% -$41.9K ﹤0.01% 645
2025
Q2 		$710K Sell
1,853
-693
-27% -$250K ﹤0.01% 635
2025
Q1 		$880K Buy
2,546
+295
+13% +$94.9K ﹤0.01% 622
2024
Q4 		$676K Buy
2,251
+25
+1% +$8.74K ﹤0.01% 608
2024
Q3 		$905K Buy
2,226
+442
+25% +$162K ﹤0.01% 598
2024
Q2 		$574K Buy
1,784
+557
+45% +$181K ﹤0.01% 595
2024
Q1 		$410K Buy
1,227
+635
+107% +$194K ﹤0.01% 593
2023
Q4 		$161K Buy
+592
New +$146K ﹤0.01% 568

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management's HCA Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its HCA Healthcare (HCA) stake by 55,869% in Q2 2026, buying an estimated $432M and bringing the position to 1,023,107 shares worth $399M. The position accounts for 0.26% of the portfolio, ranked #103.

T. Rowe Price Investment Management first reported a position in HCA in Q4 2023 and has held it in 11 quarters since. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • T. Rowe Price Investment Management held 1,023,107 shares of HCA Healthcare worth $399M as of Q2 2026.
  • T. Rowe Price Investment Management bought 1,021,279 HCA Healthcare shares in Q2 2026, an estimated $432M.
  • HCA Healthcare made up 0.26% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #103 holding.
  • T. Rowe Price Investment Management first reported a position in HCA Healthcare in Q4 2023 and has held it in 11 quarters since.
  • 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.